Pancreatic

Adjuvant Pancreatic Cancer
Metastatic Pancreatic Cancer

Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma: A Randomized Controlled Trial
WF Regine, KA Winter, RA Abrams, H Safran, JP Hoffman, A Konski, AB Benson, JS Macdonald, MR Kudrimoti, ML Fromm, MG Haddock, P Schaefer, CG Willett, & TA Rich
JAMA. Mar 5 2008; 299(9):1019-26
Journal | Pubmed

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial
H Oettle, S Post, P Neuhaus, K Gellert, J Langrehr, K Ridwelski, H Schramm, J Fahlke, C Zuelke, C Burkart, K Gutberlet, E Kettner, H Schmalenberg, K Weigang-Koehler, WO Bechstein, M Niedergethmann, I Schmidt-Wolf, L Roll, B Doerken, & H Riess
JAMA. Jan 17 2007; 297(3):267-77
Journal | Pubmed

A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
JP Neoptolemos, DD Stocken, H Friess, C Bassi, JA Dunn, H Hickey, H Beger, L Fernandez-Cruz, C Dervenis, F Lacaine, M Falconi, P Pederzoli, A Pap, D Spooner, DJ Kerr, & MW Büchler, for the European Study Group for Pancreatic Cancer
NEJM. Mar 18 2004; 350(12):1200-10
Journal | Pubmed

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205 *New*
PA Philip, J Benedetti, CL Corless, R Wong, EM O'Reilly, PJ Flynn, KM Rowland, JN Atkins, BC Mirtsching, SE Rivkin, AA Khorana, B Goldman, CM Fenoglio-Preiser, JL Abbruzzese, & CD Blanke
JCO. Aug 1 2010; 28(22):3605-3610
Journal

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) *New*
HL Kindler, D Niedzwiecki, D Hollis, S Sutherland, D Schrag, H Hurwitz, F Innocenti, M Frances Mulcahy, E O'Reilly, TF Wozniak, J Picus, P Bhargava, RJ Mayer, RL Schilsky, & RM Goldberg
JCO. Aug 1 2010; 28(22):3617-3622
Journal

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
D Cunningham, I Chau, DD Stocken, JW Valle, D Smith, W Steward, PG Harper, J Dunn, C Tudur-Smith, J West, S Falk, A Crellin, F Adab, J Thompson, P Leonard, J Ostrowski, M Eatock, W Scheithauer, R Herrmann & JP Neoptolemos
JCO Early Release. Oct 26 2009 (ahead of print)
Journal

Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
A Sultana, CT Smith, D Cunningham, N Starling, JP Neoptolemos, & P Ghaneh
JCO. Jun 20 2007; 25(18):2607-15
Journal | Pubmed

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
R Herrmann, G Bodoky, T Ruhstaller, B Glimelius, E Bajetta, J Schüller, P Saletti, J Bauer, A Figer, B Pestalozzi, CH Köhne, W Mingrone, SM Stemmer, K Tàmas, GV Kornek, D Koeberle, S Cina, J Bernhard, D Dietrich, & W Scheithauer
JCO. Jun 1 2007; 25(16):2212-7
Journal | Pubmed

Lessons Learned in the Management of Advanced Pancreatic Cancer
E Van Cutsem, C Verslype, & PA Grusenmeyer
JCO. May 20 2007; 25(15):1949-52
Editorial | Pubmed

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
MJ Moore, D Goldstein, J Hamm, A Figer, JR Hecht, S Gallinger, HJ Au, P Murawa, D Walde, RA Wolff, D Campos, R Lim, K Ding, G Clark, T Voskoglou-Nomikos, M Ptasynski, & W Parulekar
JCO. May 20 2007; 25(15):1960-6
Journal | Pubmed

Primary Links